{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:24:52Z","timestamp":1787678692533,"version":"build-2784847793"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018784","name":"Indian Institute of Technology (BHU) Varanasi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejmech.2024.116409","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T05:59:54Z","timestamp":1713247194000},"page":"116409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy"],"prefix":"10.1016","volume":"271","author":[{"given":"Digambar Kumar","family":"Waiker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"Gajendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Namrata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anima","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra Kumar","family":"Trigun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saripella","family":"Srikrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairam","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Jo","family":"Davisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5500-4004","authenticated-orcid":false,"given":"Sushant Kumar","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2019","key":"10.1016\/j.ejmech.2024.116409_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"Alzheimer's disease facts and figures","volume":"15","author":"Association","year":"2019","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ejmech.2024.116409_bib2","doi-asserted-by":"crossref","first-page":"9862","DOI":"10.1038\/srep09862","article-title":"Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant \u03b1-Synuclein","volume":"5","author":"Ahsan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116409_bib3","first-page":"2016","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"1996","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2024.116409_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/0891988712466457","article-title":"Pain in people with Alzheimer disease: potential applications for psychophysical and neurophysiological research","volume":"25","author":"Monroe","year":"2012","journal-title":"J. Geriatr. Psychiatr. Neurol."},{"key":"10.1016\/j.ejmech.2024.116409_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/JAD-161247","article-title":"Efficacy of antidepressants for depression in Alzheimer's disease: systematic review and meta-analysis","volume":"58","author":"Orgeta","year":"2017","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.ejmech.2024.116409_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/1567205017666200304085513","article-title":"Learning from the past: a review of clinical trials targeting amyloid, tau and neuroinflammation in Alzheimer's disease","volume":"17","author":"Ceyz\u00e9riat","year":"2020","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2024.116409_bib7","first-page":"1471","article-title":"Disease-modifying drugs in Alzheimer's disease","author":"Ghezzi","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2024.116409_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/d41586-021-01763-9","article-title":"Alzheimer's drug approval could afect other diseases","volume":"595","author":"Mullard","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116409_bib9","first-page":"1","article-title":"Therapeutic approaches using natural substances on the streptozotocin-induced animal model of sporadic Alzheimer's disease: a systematic review","author":"Alexandre-Silva","year":"2023","journal-title":"Advances in Traditional Medicine"},{"key":"10.1016\/j.ejmech.2024.116409_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijbiomac.2020.11.192","article-title":"Review on Alzheimer's disease: inhibition of amyloid beta and tau tangle formation","volume":"167","author":"Ashrafian","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2024.116409_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in Alzheimer's disease","volume":"4","author":"Huang","year":"2016","journal-title":"Biomedical reports"},{"key":"10.1016\/j.ejmech.2024.116409_bib12","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer's disease: the prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2024.116409_bib13","series-title":"The Role of CREB Signaling in Alzheimer's Disease and Other Cognitive Disorders","author":"Saura","year":"2011"},{"key":"10.1016\/j.ejmech.2024.116409_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.26599\/BSA.2018.2018.9050009","article-title":"How could N-methyl-D-aspartate receptor antagonists lead to excitation instead of inhibition?","volume":"4","author":"Su","year":"2018","journal-title":"Brain Science Advances"},{"key":"10.1016\/j.ejmech.2024.116409_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/11795735211029113","article-title":"The state of the art on acetylcholinesterase inhibitors in the treatment of Alzheimer's disease","volume":"13","author":"Vecchio","year":"2021","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.ejmech.2024.116409_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2005.03.020","article-title":"Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models","volume":"20","author":"Ferrer","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2024.116409_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.61","article-title":"Plasma DYRK1A as a novel risk factor for Alzheimer's disease","volume":"4","author":"Janel","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejmech.2024.116409_bib18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1474-4422(16)00063-6","article-title":"Dementia in Down's syndrome","volume":"15","author":"Ballard","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2024.116409_bib19","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/ejhg.2015.29","article-title":"Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A","volume":"23","author":"Bronicki","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmech.2024.116409_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neulet.2016.04.014","article-title":"The GBA, DYRK1A and MS4A6A polymorphisms influence the age at onset of Chinese Parkinson patients","volume":"621","author":"Fan","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2024.116409_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108661","article-title":"ADAM10 in Alzheimer's disease: pharmacological modulation by natural compounds and its role as a peripheral marker","volume":"113","author":"Manzine","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116409_bib22","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1471-4159.2007.05075.x","article-title":"Dual\u2010specificity tyrosine (Y)\u2010phosphorylation regulated kinase 1A\u2010mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease","volume":"104","author":"Ryoo","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2024.116409_bib23","doi-asserted-by":"crossref","first-page":"34850","DOI":"10.1074\/jbc.M707358200","article-title":"DYRK1A-mediated hyperphosphorylation of tau","volume":"282","author":"Ryoo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib24","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1471-4159.2010.06769.x","article-title":"Dyrk1A\u2010mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease","volume":"115","author":"Ryu","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2024.116409_bib25","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/acel.12648","article-title":"Dyrk1 inhibition improves Alzheimer's disease\u2010like pathology","volume":"16","author":"Branca","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejmech.2024.116409_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.freeradbiomed.2020.08.030","article-title":"The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation","volume":"160","author":"Lee","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2024.116409_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13000","article-title":"Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: a potential therapeutic for Alzheimer's disease","volume":"18","author":"Melchior","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejmech.2024.116409_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-019-0678-6","article-title":"Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP\/PS1 mice","volume":"7","author":"Souchet","year":"2019","journal-title":"Acta neuropathologica communications"},{"key":"10.1016\/j.ejmech.2024.116409_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105562","article-title":"The molecular mechanism, targets, and novel molecules in the treatment of Alzheimer's disease","volume":"119","author":"Verma","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106749","article-title":"Design and development of benzyl piperazine linked 5-phenyl-1, 2, 4-triazole-3-thione conjugates as potential agents to combat Alzheimer's disease","volume":"139","author":"Kiran","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5607\/en.2013.22.4.244","article-title":"New perspectives of Dyrk1A role in neurogenesis and neuropathologic features of Down syndrome","volume":"22","author":"Park","year":"2013","journal-title":"Experimental neurobiology"},{"key":"10.1016\/j.ejmech.2024.116409_bib32","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1021\/acschemneuro.3c00245","article-title":"Design, synthesis, and biological evaluation of piperazine and N-benzylpiperidine hybrids of 5-phenyl-1, 3, 4-oxadiazol-2-thiol as potential multitargeted ligands for alzheimer\u2019s disease therapy","volume":"14","author":"Waiker","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116409_bib33","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","article-title":"Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus","volume":"13","author":"Mushtaq","year":"2014","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.ejmech.2024.116409_bib34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejmech.2019.02.030","article-title":"Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease","volume":"167","author":"Sharma","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejmech.2018.08.093","article-title":"DYRK1A kinase inhibition with emphasis on neurodegeneration: a comprehensive evolution story-cum-perspective","volume":"158","author":"Pathak","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib36","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1021\/acschemneuro.9b00430","article-title":"Novel molecular hybrids of n-benzylpiperidine and 1, 3, 4-oxadiazole as multitargeted therapeutics to treat alzheimer's disease","volume":"10","author":"Sharma","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116409_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bioorg.2018.12.017","article-title":"Biphenyl-3-oxo-1, 2, 4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory","volume":"85","author":"Tripathi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib38","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1016\/j.bmc.2010.04.097","article-title":"Synthesis and in vitro evaluation of novel 1, 2, 4-triazine derivatives as neuroprotective agents","volume":"18","author":"Irannejad","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ardp.201400400","article-title":"Design, synthesis and in vitro study of 5, 6\u2010diaryl\u20101, 2, 4\u2010triazine\u20103\u2010ylthioacetate derivatives as COX\u20102 and \u03b2\u2010amyloid aggregation inhibitors","volume":"348","author":"Dadashpour","year":"2015","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2024.116409_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bioorg.2018.11.038","article-title":"Multi-target inhibitors against Alzheimer disease derived from 3-hydrazinyl 1, 2, 4-triazine scaffold containing pendant phenoxy methyl-1, 2, 3-triazole: design, synthesis and biological evaluation","volume":"84","author":"Yazdani","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib41","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1016\/j.bmcl.2014.08.054","article-title":"Computational & experimental evaluation of the structure\/activity relationship of \u03b2-carbolines as DYRK1A inhibitors","volume":"24","author":"Drung","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116409_bib42","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1021\/acsomega.2c08061","article-title":"Development and evaluation of some molecular hybrids of N-(1-Benzylpiperidin-4-yl)-2-((5-phenyl-1, 3, 4-oxadiazol-2-yl) thio) as multifunctional agents to combat alzheimer's disease","volume":"8","author":"Waiker","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2024.116409_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135517","article-title":"Discovery of novel dual acetylcholinesterase and butyrylcholinesterase inhibitors using machine learning and structure-based drug design","volume":"1286","author":"Tripathi","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116409_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132979","article-title":"Drug reposition-based design, synthesis, and biological evaluation of dual inhibitors of acetylcholinesterase and \u03b2-Secretase for treatment of Alzheimer's disease","volume":"1262","author":"Shrivastava","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116409_bib45","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A\u03b2 accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2024.116409_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131152","article-title":"Design, synthesis, and evaluation of some novel biphenyl imidazole derivatives for the treatment of Alzheimer's disease","volume":"1246","author":"Ramrao","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116409_bib47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib48","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1087057115625190","article-title":"Characterization of differentiated SH-SY5Y as neuronal screening model reveals increased oxidative vulnerability","volume":"21","author":"Forster","year":"2016","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2024.116409_bib49","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4014\/jmb.2101.01002","article-title":"Neuroprotective effect of epalrestat on hydrogen peroxide-induced neurodegeneration in SH-SY5Y cellular model","volume":"31","author":"Lingappa","year":"2021","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2024.116409_bib50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/cn200113z","article-title":"Potential of a \u03b3-glutamyl-transpeptidase-stable glutathione analogue against amyloid-\u03b2 toxicity","volume":"3","author":"More","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116409_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1021\/acschemneuro.1c00443","article-title":"Exploration of neuroprotective properties of a naturally inspired multifunctional molecule (F24) against oxidative stress and amyloid \u03b2 induced neurotoxicity in Alzheimer's disease models","volume":"13","author":"Singh","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116409_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104922","article-title":"Design, synthesis, and evaluation of N-benzylpyrrolidine and 1, 3, 4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease","volume":"111","author":"Choubey","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib53","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/cn300076x","article-title":"Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (A\u03b2) self-assembly","volume":"3","author":"Jameson","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116409_bib54","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","article-title":"Thioflavine T interaction with synthetic Alzheimer's disease \u03b2\u2010amyloid peptides: detection of amyloid aggregation in solution","volume":"2","author":"Levine","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2024.116409_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115145","article-title":"Discovery of multi-target directed 3-OH pyrrolidine derivatives through a semisynthetic approach from alkaloid vasicine for the treatment of Alzheimer's disease","volume":"249","author":"Bhanukiran","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib56","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1039\/C8CC00167G","article-title":"Real-time monitoring of the aggregation of Alzheimer's amyloid-\u03b2 via 1 H magic angle spinning NMR spectroscopy","volume":"54","author":"Wang","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.116409_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3844\/ajbbsp.2014.31.39","article-title":"Scanning electron microscope imaging of amyloid fibrils","volume":"10","author":"Takai","year":"2014","journal-title":"Am. J. Biochem. Biotechnol."},{"key":"10.1016\/j.ejmech.2024.116409_bib58","doi-asserted-by":"crossref","first-page":"8616","DOI":"10.1021\/acs.jmedchem.5b01222","article-title":"Design, synthesis, and evaluation of orally available clioquinol-moracin M hybrids as multitarget-directed ligands for cognitive improvement in a rat model of neurodegeneration in Alzheimer's disease","volume":"58","author":"Wang","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib59","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2024.116409_bib60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116409_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111613","article-title":"Discovery of novel series of 2-substituted benzo [d] oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease","volume":"182","author":"Gutti","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib62","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1021\/cn5001815","article-title":"First selective dual inhibitors of tau phosphorylation and beta-amyloid aggregation, two major pathogenic mechanisms in Alzheimer's disease","volume":"5","author":"Mariano","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116409_bib63","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116409_bib64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/bj1290197","article-title":"The graphical determination of Km and Ki","volume":"129","author":"Dixon","year":"1972","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.116409_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111707","article-title":"Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1, 3, 4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease","volume":"183","author":"Tripathi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib66","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"[18] Quantification of \u03b2-sheet amyloid fibril structures with thioflavin T","author":"LeVine","year":"1999"},{"key":"10.1016\/j.ejmech.2024.116409_bib67","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1080\/14756366.2021.1909580","article-title":"Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo [1, 3] dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004): in vitro and in vivo studies","volume":"36","author":"Mishra","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib68","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omto.2020.09.003","article-title":"Exploring the role of TRIP-Brs in human breast cancer: an investigation of expression, clinicopathological significance, and prognosis","volume":"19","author":"Mongre","year":"2020","journal-title":"Molecular Therapy-Oncolytics"},{"key":"10.1016\/j.ejmech.2024.116409_bib69","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1021\/jm400567s","article-title":"Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease","volume":"56","author":"Lu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib70","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2014.04.032","article-title":"Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice","volume":"573","author":"Jin","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2024.116409_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147733","article-title":"A comprehensive behavioral test battery to assess learning and memory in 129S6\/Tg2576 mice","volume":"11","author":"Wolf","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116409_bib72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000136485","article-title":"Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite","volume":"11","author":"Jollow","year":"1974","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejmech.2024.116409_bib73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejmech.2024.116409_bib74","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00210-019-01737-9","article-title":"Neurorestorative effects of sub-chronic administration of ambroxol in rodent model of Parkinson's disease","volume":"393","author":"Mishra","year":"2020","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116409_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153872","article-title":"Neuroprotective potential of flavonoid rich Ascophyllum nodosum (FRAN) fraction from the brown seaweed on an A\u03b242 induced Alzheimer's model of Drosophila","volume":"95","author":"Chauhan","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2024.116409_bib76","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1039\/C9OB01398A","article-title":"Logic gate behavior and intracellular application of a fluorescent molecular switch for the detection of Fe 3+ and cascade sensing of F\u2212 in pure aqueous media","volume":"17","author":"Dwivedi","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.116409_bib77","series-title":"Neuroprotective Role of a Novel Copper Chelator against A","author":"Singh","year":"2013"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T05:34:13Z","timestamp":1717220053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424002897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":77,"alternative-id":["S0223523424002897"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116409","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116409"}}